Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

View All Documentation

EHU010411

Sigma-Aldrich

MISSION® esiRNA

targeting human PGP

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

GACCCGCACTTCAGCTACATGAAGCTCACCAAGGCCCTGCGCTACCTGCAGCAGCCCGGCTGCCTGCTCGTGGGCACCAACATGGACAACCGGCTTCCGCTTGAGAACGGCCGCTTCATCGCGGGTACCGGGTGTCTGGTCCGAGCCGTGGAGATGGCCGCCCAGCGCCAGGCCGACATCATCGGGAAGCCCAGCCGCTTCATTTTCGACTGCGTGTCCCAGGAATACGGCATCAACCCCGAGCGCACCGTCATGGTGGGAGACCGCCTGGACACAGACATCCTCCTAGGCGCCACCTGTGGCCTGAAGACCATCCTGACCCTCACCGGAGTCTCCACTCTAGGGGATGTGAAGAATAATCAGGAAAGTGACTGCGTGTCTAAGAAGAAAATGGTCCCTGACTTCTATGTTGACAGCATAGCCGACCTTTTG

Ensembl | human accession no.

ENSG00000184207

NCBI accession no.

NM_001042371

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... PGP(283871) , PGP(283871)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Patric J Jansson et al.
The Journal of biological chemistry, 290(15), 9588-9603 (2015-02-28)
Multidrug resistance (MDR) is a major obstacle in cancer treatment. More than half of human cancers express multidrug-resistant P-glycoprotein (Pgp), which correlates with a poor prognosis. Intriguingly, through an unknown mechanism, some drugs have greater activity in drug-resistant tumor cells

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service